To determine whether ALKBH5 expression in NSCLC tissues correlates with immunotherapy response, we collected paraffin-embedded tissue samples from 55 patients with advanced NSCLC who received immunotherapy. Here, ALKBH5 is linked to non-small cell lung carcinoma.